Clinical Trials Browser

Recruiting × Interventional × vorolanib × Clear all

NCT07386158 2026-02-04

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

Phase 2 Recruiting

Carcinoma, Renal Cell